Response prediction of 177Lu-PSMA-617 radioligand therapy using prostate-specific antigen, chromogranin A, and lactate dehydrogenase - Rathke, Hendrik; Holland-Letz, Tim; Mier, Walter; Flechsig, Paul; Mavriopoulou, Eleni; Röhrich, Manuel; Kopka, Klaus; Hohenfellner, Markus; Giesel, Frederik L.; Haberkorn, Uwe; Kratochwil, Clemens (Journal of nuclear medicine, 2020)
Published online Oct. 25, 2019